Bisphosphonates inhibit IL-6 production by human osteoblast-like cells
- 1 January 1998
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Rheumatology
- Vol. 27 (1) , 38-41
- https://doi.org/10.1080/030097498441155
Abstract
(1998). Bisphosphonates inhibit IL-6 production by human osteoblast-like cells. Scandinavian Journal of Rheumatology: Vol. 27, No. 1, pp. 38-41.Keywords
This publication has 10 references indexed in Scilit:
- Bisphosphonates: mechanisms of action.Journal of Clinical Investigation, 1996
- Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formationJournal of Bone and Mineral Research, 1996
- Interleukin-6 in human multiple myelomaBlood, 1995
- Clodronate (dichloromethylene bisphosphonate) inhibits LPS-stimulated IL-6 and TNF production by raw 264 cellsLife Sciences, 1994
- Increased Osteoclast Development After Estrogen Loss: Mediation by Interleukin-6Science, 1992
- 17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens.Journal of Clinical Investigation, 1992
- Interleukin 6. A potential autocrine/paracrine factor in Paget's disease of bone.Journal of Clinical Investigation, 1992
- IL-6 is produced by osteoblasts and induces bone resorption.The Journal of Immunology, 1990
- Comparative antiinflammatory and bone protective effects of two diphosphonates in adjuvant arthritisArthritis & Rheumatism, 1979